TAGLIAFICO, Enrico
 Distribuzione geografica
Continente #
NA - Nord America 23.630
EU - Europa 12.057
AS - Asia 10.092
SA - Sud America 1.494
AF - Africa 219
OC - Oceania 53
Continente sconosciuto - Info sul continente non disponibili 29
Totale 47.574
Nazione #
US - Stati Uniti d'America 23.325
GB - Regno Unito 3.776
SG - Singapore 3.035
CN - Cina 2.939
IT - Italia 2.466
HK - Hong Kong 1.718
SE - Svezia 1.368
BR - Brasile 1.207
DE - Germania 1.097
VN - Vietnam 664
RU - Federazione Russa 633
FI - Finlandia 444
TR - Turchia 424
FR - Francia 399
UA - Ucraina 395
NL - Olanda 364
KR - Corea 281
ID - Indonesia 234
IN - India 225
IE - Irlanda 219
BG - Bulgaria 191
CA - Canada 186
SI - Slovenia 156
JP - Giappone 106
AR - Argentina 105
PL - Polonia 95
ZA - Sudafrica 86
MX - Messico 75
BE - Belgio 73
ES - Italia 68
BD - Bangladesh 66
IQ - Iraq 61
CZ - Repubblica Ceca 56
EC - Ecuador 55
IR - Iran 53
LT - Lituania 49
AT - Austria 48
AU - Australia 45
PK - Pakistan 44
CO - Colombia 38
MA - Marocco 31
AE - Emirati Arabi Uniti 30
CL - Cile 29
MY - Malesia 29
CH - Svizzera 28
EG - Egitto 23
KE - Kenya 23
IL - Israele 22
GR - Grecia 21
RO - Romania 21
EU - Europa 19
UZ - Uzbekistan 19
QA - Qatar 16
TW - Taiwan 16
VE - Venezuela 16
NO - Norvegia 15
PE - Perù 15
PY - Paraguay 14
TN - Tunisia 12
AZ - Azerbaigian 10
PT - Portogallo 10
SA - Arabia Saudita 10
JM - Giamaica 9
KG - Kirghizistan 9
MD - Moldavia 9
PH - Filippine 9
TH - Thailandia 9
UY - Uruguay 9
GE - Georgia 8
HU - Ungheria 8
KZ - Kazakistan 8
NP - Nepal 8
NZ - Nuova Zelanda 8
AL - Albania 7
TT - Trinidad e Tobago 7
KW - Kuwait 6
PA - Panama 6
BH - Bahrain 5
DK - Danimarca 5
DO - Repubblica Dominicana 5
DZ - Algeria 5
LV - Lettonia 5
MK - Macedonia 5
NG - Nigeria 5
RS - Serbia 5
SY - Repubblica araba siriana 5
A2 - ???statistics.table.value.countryCode.A2??? 4
AO - Angola 4
BB - Barbados 4
BO - Bolivia 4
CI - Costa d'Avorio 4
ET - Etiopia 4
GH - Ghana 4
HR - Croazia 4
IS - Islanda 4
JO - Giordania 4
SN - Senegal 4
XK - ???statistics.table.value.countryCode.XK??? 4
AM - Armenia 3
BA - Bosnia-Erzegovina 3
Totale 47.517
Città #
Southend 2.721
Fairfield 2.414
Santa Clara 2.301
Ashburn 2.172
Singapore 1.898
Hong Kong 1.683
Chandler 1.515
Woodbridge 1.469
Houston 1.109
Seattle 879
Hefei 828
Ann Arbor 806
Nyköping 775
Wilmington 745
Cambridge 736
Jacksonville 687
Dearborn 621
London 565
Beijing 550
Chicago 499
Modena 455
Los Angeles 441
New York 309
Seoul 265
San Diego 262
Amsterdam 257
Helsinki 245
Izmir 228
Dublin 211
Salt Lake City 204
Ho Chi Minh City 193
Munich 193
Council Bluffs 192
Princeton 191
Jakarta 190
Sofia 189
The Dalles 176
Moscow 164
Milan 161
Shanghai 154
Eugene 138
Hanoi 135
Bologna 125
Buffalo 125
São Paulo 120
Fremont 112
Tampa 111
Dallas 110
Elk Grove Village 106
Bremen 94
Rome 78
Falls Church 76
Frankfurt am Main 75
Tokyo 74
Des Moines 73
Redwood City 71
Turku 65
Brussels 64
Reggio Emilia 61
Warsaw 61
Columbus 59
Denver 59
Phoenix 58
Toronto 57
Parma 55
Nuremberg 54
Orem 54
Boardman 53
Dong Ket 53
Johannesburg 53
Guangzhou 49
Montreal 48
San Jose 47
Sterling 46
Lancaster 45
Brooklyn 42
Poplar 41
Atlanta 38
Stockholm 37
Brno 36
Ottawa 36
Rio de Janeiro 36
Florence 33
Sant'Ilario d'Enza 33
Verona 33
Kent 31
Norwalk 31
Chennai 30
Miami 30
Da Nang 29
Kunming 29
Mexico City 29
San Francisco 29
Vienna 29
Belo Horizonte 28
Boston 28
Brasília 28
Turin 28
Bari 27
Palermo 27
Totale 33.115
Nome #
Targeted cancer exome sequencing reveals recurrent mutations in myeloproliferative neoplasms 500
c-Myb supports erythropoiesis through the transactivation of KLF1 and LMO2 expression. 458
A Next Generation Sequencing amplicon-based strategy to explore Inherited Retinal Degeneration complexity 450
Embryonic stem-derived versus somatic neural stem cells: A comparative analysis of their developmental potential and molecular phenotype 425
Transcriptional profiles underlying vulnerability and resilience in rats exposed to an acute unavoidable stress 417
Implementation of an NGS-based workflow for BRCA1 and BRCA2 mutation screening 410
The barley Frost resistance-H2 locus 405
Virally mediated MafB transduction induces the monocyte commitment of human CD34+ hematopoietic stem/progenitor cells 389
KLF4 mediates the effect of 5-ASA on the b-catenin pathway in colon cancer cells 377
Deregulated expression of miR-29a-3p, miR-494-3p and miR-660-5p affects sensitivity to tyrosine kinase inhibitors in CML leukemic stem cells 376
Involvement of MAF/SPP1 axis in the development of bone marrow fibrosis in PMF patients 376
Gene expression profiling of normal and malignant CD34-derived megakaryocytic cells 373
Cytogenetic abnormalities and clinical features in a patient cohort affected by three or more synchronous or metachronous primitive malignancies. 370
Self-Renewing Osteoprogenitors in Bone Marrow Sinusoids Can Organize a Hematopoietic microenvironment 362
NF-YA splice variants have different roles on muscle differentiation 359
MafB is a downstream target of the IL-10/STAT3 signaling pathway, involved in the regulation of macrophage de-activation 353
Correlation between differentiation plasticity and mRNA expression profiling of CD34+-derived CD14- and CD14+ human normal myeloid precursors 353
A balance between NF-Y and p53 governs the pro- and anti-apoptotic transcriptional response 346
Unravelling the Complexity of Inherited Retinal Dystrophies Molecular Testing: Added Value of Targeted Next-Generation Sequencing 339
Expression of μ-protocadherin is negatively regulated by the activation of the β-catenin signaling pathway in normal and cancer colorectal enterocytes 337
Mutations and prognosis in primary myelofibrosis 335
miR-494-3p overexpression promotes megakaryocytopoiesis in primary myelofibrosis hematopoietic stem/progenitor cells by targeting SOCS6 332
ERBB2 mutations in hormone receptor positive primary breast cancers samples and in their matched endocrine-resistant recurrences. 331
The kinetic status of hematopoietic stem cell subpopulations underlies a differential expression of genes involved in self-renewal, commitment, and engraftment. 331
Transcriptional profiles in melanocytes from clinically unaffected skin distinguish the neoplastic growth pattern in patients with melanoma 326
Suppression of bile acid synthesis, but not of hepatic cholesterol 7alpha-hydroxylase expression, by obstructive cholestasis in humans 323
Calreticulin Ins5 and Del52 mutations impair unfolded protein and oxidative stress responses in K562 cells expressing CALR mutants 323
Abstracts from the 55th European Society of Human Genetics (ESHG) Conference: Hybrid Posters 322
Integrative Analysis Of mRNA/miRNA Expression Profiles Identified JARID2 As a Shared Target Of Deregulated Mirnas In Primary Myelofibrosis 322
Transplantation of genetically corrected human iPSC-derived progenitors in mice with limb-girdle muscular dystrophy 319
miRNA-mRNA integrative analysis in primary myelofibrosis CD34+ cells: role of miR-155/JARID2 axis in abnormal megakaryopoiesis 317
No Identical ‘‘Mesenchymal Stem Cells’’ at Different Times and Sites: Human Committed Progenitors of Distinct Origin and Differentiation Potential Are Incorporated as Adventitial Cells in Microvessels 317
Intrinsic phenotypic diversity of embryonic and fetal myoblasts is revealed by genome-wide gene expression analysis on purified cells 315
From gating to computational flow cytometry: Exploiting artificial intelligence for MRD diagnostics 314
Gene expression in grapevine cultivars in response to BOIS NOIR phytoplasma infection 313
Genomic alterations at the basis of treatment resistance in metastatic breast cancer: Clinical applications 313
Retroviral vector integration deregulates gene expression but has no consequence on the biology and function of transplanted T cells 311
Integrated evaluation of PAM50 subtypes and immune modulation of pCR in HER2-positive breast cancer patients treated with chemotherapy and HER2-targeted agents in the CherLOB trial 311
Identification of a molecular signature predictive of sensitivity to differentiation induction in acute myeloid leukemia 311
Amplicon-based Next Generation Sequencing: an effective approach to molecular diagnosis of Epidermolysis Bullosa 310
Ceruloplasmin gene variants are associated with hyperferritinemia and increased liver iron in patients with {NAFLD} 310
Calreticulin affects hematopoietic stem/progenitor cell fate by impacting erythroid and megakaryocytic differentiation 308
Acute myeloid leukemia in patients living with HIV infection: Several questions, fewer answers 308
CALR mutational status identifies different disease subtypes of essential thrombocythemia showing distinct expression profiles 307
Antisense inhibition of c-fes proto-oncogene blocks PMA-induced macrophage differentiation in HL60 and in FDC-P1/MAC-11 cells 306
Amplicon-based next-generation sequencing: an effective approach for the molecular diagnosis of epidermolysis bullosa 305
Microarray analysis of the chronic escape deficit model of depression: Effects of escitalopram treatment in hippocampus 302
Epidemiology and clinical relevance of mutations in postpolycythemia vera and postessential thrombocythemia myelofibrosis: A study on 359 patients of the AGIMM group 302
Abnormal expression patterns of WT1-as, MEG3 and ANRIL long non-coding RNAs in CD34+ cells from patients with primary myelofibrosis and their clinical correlations 301
Effects of bile duct ligation and cholic acid treatment on fatty liver in two rat models of non-alcoholic fatty liver disease 300
Role of miR-34a-5p in Hematopoietic Progenitor Cells Proliferation and Fate Decision: Novel Insights into the Pathogenesis of Primary Myelofibrosis 297
Role of TGF-β1/miR-382-5p/SOD2 axis in the induction of oxidative stress in CD34+ cells from primary myelofibrosis 295
Requirement of the coiled-coil domains of p92(c-Fes) for nuclear localization in myeloid cells upon induction of differentiation 290
ALTERATA REATTIVITA’ MACROFAGICA IN CORSO DI INFEZIONE MISTA DA VIRUS E FUNGHI:VALUTAZIONI FUNZIONALI, CITOFLUORIMETRICHE E DI ESPRESSIONE GENICA 286
Gene expression profile of vitamin D3 treated HL60 cells shows an incomplete molecular phenotypic conversion to monocytes 284
Hereditary pancreatic cancer: A retrospective single-center study of 5143 Italian families with history of BRCA-related malignancies 284
Integrated analysis of microRNA and mRNA expression profiles in physiological myelopoiesis: role of hsa-mir-299-5p in CD34+ progenitor cells commitment 282
Impact of mutational status on outcomes in myelofibrosis patients treated with ruxolitinib in the COMFORT-II study 279
TGFβ/BMP activate the smooth muscle/bone differentiation programs in mesoangioblasts 278
Gene expression profiles of human granulosa cells treated with bioequivalent doses of corifollitropin alfa (CFA) or recombinant human follicle-stimulating hormone (recFSH) 276
Identification of a molecular signature for leukemic promyelocytes and their normal counterparts: focus on DNA repair genes 275
Valproic acid triggers erythro/megakaryocyte lineage decision through induction of GFI1B and MLLT3 expression 273
Monocyte Distribution Width (MDW) as novel inflammatory marker with prognostic significance in COVID-19 patients 272
Regulation of ob gene expression: evidence for epinephrine-induced suppression in human obesity 271
Polarization dictates iron handling by inflammatory and alternatively activated macrophages 269
Correlation between eight-gene expression profiling and response to therapy of newly diagnosed multiple myeloma patients treated with thalidomide-dexamethasone incorporated into double autologous transplantation. 266
Isolation of human keratinocyte stem cells and high-throughput screening approach for their characterization 265
A functionally active RAR alpha nuclear receptor is expressed in retinoic acid non responsive early myeloblastic cell lines 264
HGM 2010 Programme / Abstract 264
Usefulness and limitations of comprehensive characterization of mRNA splicing profiles in the definition of the clinical relevance of BRCA1/2 variants of uncertain significance 262
Final results of a phase II randomized trial of neoadjuvant anthracycline-taxane chemotherapy plus lapatinib, trastuzumab, or both in HER2-positive breast cancer (CHER-LOB trial). 261
Identification of new p63 targets in human keratinocytes 256
Differentiated Neuroprogenitor Cells Incubated with Human or Canine Adenovirus, or Lentiviral Vectors Have Distinct Transcriptome Profiles 256
Double-blind, placebo-controlled, multicentric randomized phase IIb neoadjuvant study of letrozole-lapatinib in postmenopausal HER2-negative, hormone receptor-positive operable breast cancer 256
Gene expression profiling of monocytes displaying herpes simplex virus 1 induced dysregulation of antifungal defences 255
Brca detection rate in an italian cohort of luminal early-onset and triple-negative breast cancer patients without family history: When biology overcomes genealogy 255
Regulatory Mrna/Microrna Networks in CD34+ Cells From Primary Myelofibrosis 254
Double-blind, placebo-controlled, multicenter, randomized, phase IIb neoadjuvant study of letrozole-lapatinib in postmenopausal hormone receptor-positive, human epidermal growth factor receptor 2-negative, operable breast cancer 254
Microarray analysis in hippocampus of rats treated with escitalopram in the chronic escape deficit model of depression 254
Impact Of Prognostically Detrimental Mutations (ASXL1, EZH2, SRSF2, IDH1/2) On Outcomes In Patients With Myelofibrosis Treated With Ruxolitinib In COMFORT-II 253
DIAGNOSI MOLECOLARE DELLE IPERTRIGLICERIDEMIE PRIMITIVE ATTRAVERSO “NGS” (NEXT GENERATION SEQUENCING) 248
Integrated analysis of microRNA and mRNA expression profiles in physiological myelopoieis: role of hsa-miR-299-5p in CD34+ progenitor cells commitment 247
Transcriptional changes in grapevine in response to Bois Noir infection 246
Ex vivo treatment with nitric oxide increases mesoangioblast therapeutic efficacy in muscular dystrophy 245
Nfix Regulates Fetal-Specific Transcription in Developing Skeletal Muscle 245
Prospective biomarker analysis of the randomized CHER-LOB study evaluating the dual anti-HER2 treatment with trastuzumab and lapatinib plus chemotherapy as neoadjuvant therapy for HER2-positive breast cancer 245
Antiapoptotic effect of c-fes protooncogene during granulocytic differentiation 245
Identification of miR-31-5p, miR-141-3p, miR-200c-3p, and GLT1 as human liver aging markers sensitive to donor-recipient age-mismatch in transplants 242
A multivariable prognostic score to guide systemic therapy in early-stage HER2-positive breast cancer: a retrospective study with an external evaluation 241
FOXP1 and TP63 involvement in the progression of myelodysplastic syndrome with 5q- and additional cytogenetic abnormalities 240
Gene expression profiling in MDS and AML: potential and future avenues 239
Single-keratinocyte transcriptomic analyses identify different clonal types and proliferative potential mediated by FOXM1 in human epidermal stem cells 238
Allele specific CRISPR/Cas9 editing of dominant Epidermolysis Bullosa Simplex in human epidermal stem cells 235
Development of an IL-6 antagonist peptide that induces apoptosis in IL-6 dependent 7TD1 cells. 232
Myeloperoxidase gene expression in blast cells with a lymphoid phenotype in cases of acute lymphoblastic leukemia. 225
All-trans-retinoic acid induces simultaneously granulocytic differentiation and expression of inflammatory cytokines in HL-60 cells 224
Transcriptional Response of Human Neurospheres to helper-dependent CAV-2 vectors involves the modulation of DNA damage response, microtubule and centromere gene groups 224
MyoD expression restores defective myogenic differentiation of human mesoangioblasts from inclusion-body myositis muscle 223
IDENTIFICATION OF A MOLECULAR SIGNATURE PREDICTIVE OF REFRACTORINESS IN ACUTE MYELOID LEUKEMIA 221
STRATEGIES TO PREDICT TREATMENT RESPONSE AND SELECT THERAPIES IN METASTATIC BREAST CANCER PATIENTS USING A NEXT GENERATION SEQUENCING MULTI-GENE PANEL 220
Totale 30.031
Categoria #
all - tutte 191.871
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 191.871


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20212.825 0 0 0 0 0 447 330 479 277 593 359 340
2021/20224.037 264 393 391 237 179 251 210 178 401 340 670 523
2022/20234.808 547 595 503 418 516 590 112 432 656 51 194 194
2023/20243.131 117 148 220 259 487 284 387 415 91 124 202 397
2024/202510.174 311 136 226 617 1.859 1.462 841 626 1.192 456 1.150 1.298
2025/202610.706 1.393 841 1.459 2.308 3.455 1.250 0 0 0 0 0 0
Totale 47.977